OncoFusion Therapeutics Inc.
Industry
- Biotechnology
See more in Biomedtracker
Latest on OncoFusion Therapeutics Inc.
Pink Sheet
• By Brenda Sandburg, Sten Stovall, John Davis, and Malcolm Spicer
“The Pink Sheet” regularly covers significant deal-making in the biopharmaceutical sector. Below is a summary of the most noteworthy deals occurring between Aug. 22 and Aug. 28. Mylan/Perrigo Mylan
Pink Sheet
Medivation Inc. ’s next move in oncology brings it a second late-stage cancer candidate and could be the start to building up an oncology franchise beyond the partnership with Astellas Pharma Inc.
In Vivo
IN VITRO DIAGNOSTICS Alliances Abbott Laboratories Inc. Idera Pharmaceuticals Inc. Idera Pharmaceuticals Inc. (toll-like receptor (TLR) antagonists for autoimmune diseases and B-cell lymphomas) si